HSBC Holdings
IGC icon

HSBC Holdings’s IGC Pharma IGC Stock Holding History

HSBC Holdings’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-59,730
Closed -$385K – 2650
2018
Q3 		$385K Buy
+59,730
New +$62.1K ﹤0.01% 2134

Other funds holding IGC

CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

HSBC Holdings's IGC Position: Q4 2018 in Review

HSBC Holdings sold out of IGC Pharma (IGC) in Q4 2018, closing a stake of 59,730 shares — an estimated $385K sold.

HSBC Holdings first reported a position in IGC in Q3 2018 and held it in 1 quarter. The position peaked at $385K in Q3 2018. 4 funds tracked by Wall St. Rank hold IGC as of Q4 2018.

  • HSBC Holdings reported no remaining IGC Pharma position as of Q4 2018 after selling out during the quarter.
  • HSBC Holdings sold 59,730 IGC Pharma shares in Q4 2018, an estimated $385K.
  • HSBC Holdings first reported a position in IGC Pharma in Q3 2018 and held it in 1 quarter.
  • HSBC Holdings's IGC Pharma position peaked at $385K in Q3 2018.
  • 4 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2018.

Based on HSBC Holdings's 13F filing for Q4 2018, filed 13 Feb 2019.